Stay updated on LN-144 in Metastatic Uveal Melanoma Clinical Trial
Sign up to get notified when there's something new on the LN-144 in Metastatic Uveal Melanoma Clinical Trial page.

Latest updates to the LN-144 in Metastatic Uveal Melanoma Clinical Trial page
- Check6 days agoChange DetectedThe label 'Last Update Posted' on the Study Details page is updated to 'Last Update Posted (Estimated)'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedNew operating-status notice and v3.2.0 release; prior v3.1.0 revision removed.SummaryDifference3%

- Check34 days agoChange DetectedMajor update: new primary contact (Lauren Banks, MD, PhD) with updated phone, email, and address; product revision updated to v3.1.0 and origin noted; former contact and earlier revision are removed.SummaryDifference1%

- Check42 days agoChange DetectedDifference0.0%

- Check49 days agoChange DetectedBroadens eligibility by removing the 3-year prior malignancy exclusion and adds an explicit ban on active concurrent malignancies requiring systemic treatment, with an exception for adjuvant NED cancers on hormone therapy (Revision: v3.0.2, dated 2025-09-11/12).SummaryDifference6%

- Check56 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%

Stay in the know with updates to LN-144 in Metastatic Uveal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LN-144 in Metastatic Uveal Melanoma Clinical Trial page.